Use App
Trending
News
Earnings
All
DIA
0.76%
SPY
0.36%
QQQ
0.48%
Trending
SPCE
40.95%
GRRR
15.28%
DELL
31.92%
IBM
13.66%
ASTC
64.80%
CRSR
3.18%
SOFI
6.87%
FJET
10.53%
CRWD
8.48%
AMBA
20.80%
SPCE
40.95%
GRRR
15.28%
DELL
31.92%
IBM
13.66%
ASTC
64.80%
CRSR
3.18%
SOFI
6.87%
FJET
10.53%
CRWD
8.48%
AMBA
20.80%
home
Symbol
JNJ
JNJ
Johnson & Johnson
48,645
Mkt Cap
$555.59B
Volume
4.73M
52W High
$251.71
52W Low
$149.04
PE Ratio
26.69
JNJ Fundamentals
Price
$225.35
Prev Close
$230.80
Open
$231.48
50D MA
$232.75
Beta
0.05
Avg. Volume
7.63M
EPS (Annual)
$11.03
P/B
6.84
Rev/Employee
$668,877.84
$533,647.35
PE Ratio
26.69
Loading...
Loading...
Feed
News
Sentiment
Earnings
Fundamentals
Info
Compact View
Full View
Mini-Chart
Sentiment
Not available
Message Volume
Not available
Advertisement
|
Remove ads.
Latest JNJ News
View
JNJ Reports Promising Survival Data From CHRYSALIS-2 Lung Cancer Study
Stocktwits
RYBREVANT (amivantamab-vmjw) plus LAZCLUZE (lazertinib) demonstrates prolonged clinical benefit as a first-line treatment for atypical EGFR-mutated non-small cell lung cancer
PR Newswire
New TECVAYLI (teclistamab-cqyv) data demonstrate superior progression-free and overall survival as early as first relapse in multiple myeloma
PR Newswire
Top Discussions
top
active
trending
Loading...
Advertisement
|
Remove ads.
Watchlist
Trending
News
Explore
Community
Profile